Skip to main content
. 2016 Feb 21;28(6):1591–1606. doi: 10.1021/acs.chemmater.5b04281

Figure 11.

Figure 11

(a) Synthetic pathway for gemcitabine–poly(squalenyl methacrylate) (Gem-PSqMA) prodrug by reversible addition–fragmentation chain transfer (RAFT) polymerization. (b) DLS data giving the average diameter in intensity. (c) Cryo-TEM of Gem-PSqMA10 nanoparticles. The RAFT moiety was omitted on the schematic representation of the nanoparticle for clarity. Adapted with permissions from ref (68).